UnitedHealth Group (UNH) Stock Forecast & Price Target

$359.81 -1.68 (-0.46%)

As of 03:05 PM Eastern

Compare

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Hold

Based on 29 Analyst Ratings

Sell
4

Hold
7

Buy
18

Based on 29 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Hold." Out of the 29 analysts, 4 have given a sell rating, 7 have given a hold rating, and 18 have given a buy rating for UNH.

Consensus Price Target

$385.13
7.03% Upside

According to the 29 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $385.13. The highest price target for UNH is $675.00, while the lowest price target for UNH is $198.00. The average price target represents a forecasted upside of 7.03% from the current price of $359.81.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UNH Analyst Ratings Over Time

Type	Current Forecast 10/23/24 to 10/23/25	1 Month Ago 9/23/24 to 9/23/25	3 Months Ago 7/25/24 to 7/25/25	1 Year Ago 10/24/23 to 10/23/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	2 Strong Buy rating(s)
Buy	18 Buy rating(s)	16 Buy rating(s)	15 Buy rating(s)	17 Buy rating(s)
Hold	7 Hold rating(s)	6 Hold rating(s)	8 Hold rating(s)	3 Hold rating(s)
Sell	4 Sell rating(s)	3 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$385.13	$358.95	$392.29	$615.53
Forecasted Upside	7.03% Upside	3.18% Upside	39.76% Upside	9.04% Upside
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Moderate Buy

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Medical Companies	S&P 500
Consensus Rating Score	2.48	2.33	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	6.83% Upside	1,429.47% Upside	12.29% Upside
News Sentiment Rating	Positive News See Recent UNH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/17/2025	Jefferies Financial Group 2 of 5 stars	David Windley Not Rated	Boost Target	Buy	$317.00 ➝ $409.00	+14.44%
10/14/2025	The Goldman Sachs Group 3 of 5 stars	Scott Fidel Not Rated	Initiated Coverage	Buy	$406.00	+13.15%
10/9/2025	JPMorgan Chase & Co. 2 of 5 stars	Lisa Gill Not Rated	Boost Target	Overweight	$310.00 ➝ $425.00	+13.34%
10/9/2025	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$300.00 ➝ $430.00	+16.25%
10/9/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$352.00 ➝ $386.00	+4.36%
10/8/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Fischbeck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$350.00 ➝ $390.00	+5.29%
10/8/2025	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Sell (D+)
10/8/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$379.00 ➝ $433.00	+16.17%
10/8/2025	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Gillmor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$350.00 ➝ $400.00	+8.13%
10/7/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$267.00 ➝ $400.00	+11.26%
Get the Latest News and Ratings for UNH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.
10/6/2025	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
9/12/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ricky Goldwasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$325.00 ➝ $395.00	+10.44%
9/9/2025	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Macdonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$310.00 ➝ $365.00	+6.04%
8/26/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$440.00	+44.13%
7/31/2025	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold ➝ Strong Sell
7/31/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral ➝ Underperform	$312.00 ➝ $198.00	-25.68%
7/30/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$355.00 ➝ $286.00	+9.65%
7/30/2025	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$353.00 ➝ $317.00	+21.52%
7/30/2025	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$400.00 ➝ $325.00	+24.59%
7/17/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
5/21/2025	Hsbc Global Res Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	M. Herholdt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Hold ➝ Moderate Sell
5/21/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sidharth Sahoo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Hold ➝ Reduce	$490.00 ➝ $270.00	-16.09%
5/20/2025	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Justin Lake Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$501.00 ➝ $390.00	+21.90%
5/19/2025	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$520.00 ➝ $308.00	-1.39%
5/19/2025	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	R. Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$308.00	+5.75%
5/14/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$521.00 ➝ $362.00	+16.14%
5/14/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	J. Ransom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Market Perform
4/30/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	H. Engel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
4/21/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Toung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold
12/5/2024	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$605.00 ➝ $675.00	+10.54%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:53 PM ET.

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, October 22, 2025. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

Here are some ways that investors could benefit from investing in UnitedHealth Group:

The company has demonstrated strong revenue growth, with a recent quarterly revenue increase of approximately 12.9% compared to the same period last year.
UnitedHealth Group has a solid return on equity of over 23%, indicating effective management and profitability relative to shareholder equity.
The current stock price is around $385, which reflects a favorable valuation in light of the company's growth prospects and market position.
Analysts have a generally positive outlook, with many rating the stock as a "buy" and setting target prices significantly above the current price, suggesting potential for appreciation.
The company has a consistent dividend payout, with an annualized dividend yield of 2.4%, providing investors with a steady income stream.

UnitedHealth Group
Bear Case

Investors should be bearish about investing in UnitedHealth Group for these reasons:

The company recently missed earnings expectations, reporting earnings per share of $4.08, which was below the consensus estimate of $4.45, raising concerns about future performance.
UnitedHealth Group's net margin is relatively modest at around 5.04%, which may indicate challenges in maintaining profitability amidst rising costs in the healthcare sector.
There is a significant level of competition in the healthcare industry, which could impact UnitedHealth Group's market share and pricing power.
Some analysts have expressed caution, with a portion of ratings being "hold" or "sell," suggesting that not all market participants are confident in the stock's near-term prospects.
The company's dividend payout ratio is approximately 38.3%, which, while sustainable, may limit the ability to reinvest profits back into growth initiatives.

UNH Forecast - Frequently Asked Questions

: According to the research reports of 29 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $385.13, with a high forecast of $675.00 and a low forecast of $198.00.
: 29 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last twelve months. There are currently 4 sell ratings, 7 hold ratings and 18 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" UNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in UNH, but not buy additional shares or sell existing shares.
: According to analysts, UnitedHealth Group's stock has a predicted upside of 7.03% based on their 12-month stock forecasts.
: Over the previous 90 days, UnitedHealth Group's stock had 1 upgrade and 1 downgrade by analysts.
: UnitedHealth Group has been rated by research analysts at Baird R W, Bank of America, Barclays, Cantor Fitzgerald, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Oppenheimer, Piper Sandler, Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, The Goldman Sachs Group, Truist Financial, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.
: Analysts like UnitedHealth Group more than other "medical" companies. The consensus rating score for UnitedHealth Group is 2.48 while the average consensus rating score for "medical" companies is 2.33. Learn more on how UNH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:UNH) was last updated on 10/23/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Consensus Price Target

UNH Analyst Ratings Over Time

UNH Analyst Recommendations By Month

UNH Price Targets by Month

UnitedHealth Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

UnitedHealth Group
Bull Case

UnitedHealth Group
Bear Case

UNH Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Consensus Price Target

UNH Analyst Ratings Over Time

UNH Analyst Recommendations By Month

UNH Price Targets by Month

UnitedHealth Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

UnitedHealth Group Bull Case

UnitedHealth Group Bear Case

UNH Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

UnitedHealth Group
Bull Case

UnitedHealth Group
Bear Case